These results demonstrate the involvement of S100A9 and S100A11 in the initiation of NAFL, while S100A6, S100A8, and S100A10 are involved in steatosis-to-NASH progression. Here, S100A11 is linked to metabolic dysfunction-associated steatohepatitis.